100 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
24
Design, synthesis and biological evaluation of nonsecosteroidal vitamin D
China Pharmaceutical University
53
Discovery of phenoxyindazoles and phenylthioindazoles as ROR¿ inverse agonists.
Galderma R & D
12
2-(3-Methoxyphenyl)quinazoline Derivatives: A New Class of Direct Constitutive Androstane Receptor (CAR) Agonists.
Palacky University In Olomouc
5
Synthesis and Biological Evaluation of Vitamin D3 Metabolite 20S,23S-Dihydroxyvitamin D3 and Its 23R Epimer.
University of Tennessee Health Science Center
28
SAR Exploration Guided by LE and Fsp(3): Discovery of a Selective and Orally Efficacious ROR¿ Inhibitor.
Central Pharmaceutical Research Institute
14
Synthesis and evaluation of vitamin D receptor-mediated activities of cholesterol and vitamin D metabolites.
University of Wisconsin
6
A Methylene Group on C-2 of 24,24-Difluoro-19-nor-1a,25-dihydroxyvitamin D3 Markedly Increases Bone Calcium Mobilization in Vivo.
University of Wisconsin-Madison
5
Synthesis, Biological Activities, and X-ray Crystal Structural Analysis of 25-Hydroxy-25(or 26)-adamantyl-17-[20(22),23-diynyl]-21-norvitamin D Compounds.
Rikkyo University
5
Effects of alkyl side chains and terminal hydrophilicity on vitamin D receptor (VDR) agonistic activity based on the diphenylpentane skeleton.
National Institute of Health Sciences
2
Fine tuning of agonistic/antagonistic activity for vitamin D receptor by 22-alkyl chain length of ligands: 22S-Hexyl compound unexpectedly restored agonistic activity.
Showa Pharmaceutical University
4
Chemical Synthesis and Biological Activities of 20S,24S/R-Dihydroxyvitamin D3 Epimers and Their 1a-Hydroxyl Derivatives.
Veterans Affairs Medical Center
7
Novel 9-Alkyl- and 9-Alkylidene-Substituted 1a,25-Dihydroxyvitamin D3 Analogues: Synthesis and Biological Examinations.
University of Warsaw
4
Structural development of stapled short helical peptides as vitamin D receptor (VDR)-coactivator interaction inhibitors.
National Institute of Health Sciences
20
Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORß and ROR¿t.
Phenex Pharmaceuticals
1
Structural insights into the molecular mechanism of vitamin D receptor activation by lithocholic acid involving a new mode of ligand recognition.
Institute of Genetics and Molecular and Cellular Biology (Igbmc)
4
Combination of triple bond and adamantane ring on the vitamin D side chain produced partial agonists for vitamin D receptor.
Rikkyo University
11
A mixed population of antagonist and agonist binding conformers in a single crystal explains partial agonism against vitamin D receptor: active vitamin D analogues with 22R-alkyl group.
Showa Pharmaceutical University
28
Development of novel Vitamin D Receptor-Coactivator Inhibitors.
University of Wisconsin-Milwaukee
12
Novel acetamidothiazole derivatives: synthesis and in vitro anticancer evaluation.
University of Mansoura
16
Novel nonsecosteroidal VDR agonists with phenyl-pyrrolyl pentane skeleton.
China Pharmaceutical University
2
Synthesis of VS-105: A novel and potent vitamin D receptor agonist with reduced hypercalcemic effects.
Vidasym
8
Development of stapled short helical peptides capable of inhibiting vitamin D receptor (VDR)-coactivator interactions.
National Institute of Health Sciences
7
Synthesis of 2α-heteroarylalkyl active vitamin d3 with therapeutic effect on enhancing bone mineral density in vivo.
Teikyo University
95
Synthesis and evaluation of methylsulfonylnitrobenzamides (MSNBAs) as inhibitors of the thyroid hormone receptor-coactivator interaction.
St. Jude Children'S Research Hospital
17
Development of silicon-containing bis-phenol derivatives as androgen receptor antagonists: selectivity switching by C/Si exchange.
The University of Tokyo
17
Structure-activity relationship of benzodiazepine derivatives as LXXLL peptide mimetics that inhibit the interaction of vitamin D receptor with coactivators.
The University of Tokyo
1
Synthesis and biological evaluation of halogenated curcumin analogs as potential nuclear receptor selective agonists.
Arizona State University
10
Removal of the 26-methyl group from 19-nor-1a,25-dihydroxyvitamin D3 markedly reduces in vivo calcemic activity without altering in vitro VDR binding, HL-60 cell differentiation, and transcription.
University of Wisconsin-Madison
84
Further synthetic and biological studies on vitamin D hormone antagonists based on C24-alkylation and C2alpha-functionalization of 25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones.
Teikyo University
7
Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis.
University of Tokyo
4
Synthesis and biological evaluation of 1a,25-dihydroxyvitamin D3 analogues with a long side chain at C12 and short C17 side chains.
Universidad De Santiago De Compostela
6
Structural basis for the accommodation of bis- and tris-aromatic derivatives in vitamin D nuclear receptor.
Institute of Genetics and Molecular and Cellular Biology (Igbmc)
48
Discovery of the first irreversible small molecule inhibitors of the interaction between the vitamin D receptor and coactivators.
University of Wisconsin-Milwaukee
3
Butyl pocket formation in the vitamin D receptor strongly affects the agonistic or antagonistic behavior of ligands.
Showa Pharmaceutical University
8
A 20S combined with a 22R configuration markedly increases both in vivo and in vitro biological activity of 1a,25-dihydroxy-22-methyl-2-methylene-19-norvitamin D3.
University of Wisconsin-Madison
22
Novel selective anti-androgens with a diphenylpentane skeleton.
The University of Tokyo
16
Vitamin D receptor agonist/histone deacetylase inhibitor molecular hybrids.
Mcgill University
1
Synthesis, conformational analysis, and biological evaluation of 19-nor-vitamin D3 analogues with A-ring modifications.
Universidad De Oviedo
5
2-Methylene 19-nor-25-dehydro-1alpha-hydroxyvitamin D3 26,23-lactones: synthesis, biological activities and molecular basis of passive antagonism.
Tokyo Medical and Dental University
5
(2S,2'R)-analogue of LG190178 is a major active isomer.
National Institute of Health Sciences
3
Design, synthesis, and biological evaluation of a 1alpha,25-dihydroxy-19-norvitamin D3 analogue with a frozen A-ring conformation.
University of Wisconsin-Madison
4
22-Alkyl-20-epi-1alpha,25-dihydroxyvitamin D3 compounds of superagonistic activity: syntheses, biological activities and interaction with the receptor.
Tokyo Medical and Dental University
4
13,13-Dimethyl-des-C,D analogues of (20S)-1a,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): total synthesis, docking to the VDR, and biological evaluation.
University of Wisconsin-Madison
8
Design, synthesis and X-ray crystallographic study of new nonsecosteroidal vitamin D receptor ligands.
National Institute of Health Sciences
6
Synthesis and biological activity of 2-(3'-hydroxypropylidene)-1a-hydroxy-19-norvitamin D analogues with shortened alkyl side chains.
University of Warsaw
2
An o-aminoanilide analogue of 1a,25-dihydroxyvitamin D(3) functions as a strong vitamin D receptor antagonist.
Mcgill University
30
Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists.
Phenex Pharmaceuticals
10
LXXLL peptide mimetics as inhibitors of the interaction of vitamin D receptor with coactivators.
The University of Tokyo
4
Removal of the 20-methyl group from 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D(3) (2MD) selectively eliminates bone calcium mobilization activity.
University of Wisconsin-Madison
9
A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.
Showa Pharmaceutical University
2
Synthesis and biological evaluation of MC 1357, a new 20-epi-23-oxa-1α,25-dihydroxy-vitamin D3 analogue with potent non-classical effects
TBA
3
New 1alpha,25-dihydroxy-19-norvitamin D(3) compounds constrained in a single A-ring conformation: synthesis of the analogues by ring-closing metathesis route and their biological evaluation.
University of Wisconsin-Madison
3
Synthesis and anti-inflammatory properties of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-24-oxo-vitamin D3, a hypocalcemic, stable metabolite of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-vitamin D3.
Bioxell
6
13-Methyl-substituted des-C,D analogs of (20S)-1alpha,25-dihydroxy-2-methylene-19-norvitamin D3 (2MD): synthesis and biological evaluation.
University of Wisconsin-Madison
3
Synthesis and biological properties of 2-methylene-19-nor-25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactones--weak agonists.
University of Wisconsin-Madison
3
Crystal structures of rat vitamin D receptor bound to adamantyl vitamin D analogs: structural basis for vitamin D receptor antagonism and partial agonism.
Tokyo Medical and Dental University
13
Structure-activity relationship studies on vitamin D lactam derivatives as vitamin D receptor antagonist.
Tokyo University of Agriculture and Technology
9
2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.
Tokyo Medical and Dental University
48
Discovery of Highly Potent, Selective, and Liver-Targeting HSD17B13 Inhibitor with Robust In Vivo Anti-MASH Activity.
Guangdong Pharmaceutical University
1
LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2.
Eli Lilly
6
Low-calcemic, highly antiproliferative, 23-oxa ether analogs of the natural hormone 1 alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
The Johns Hopkins University
5
Further Studies on the Highly Active Des-C-Ring and Aromatic-D-Ring Analogues of 1α,25-Dihydroxyvitamin D
University of Santiago De Compostela
27
Development of a Potent Nurr1 Agonist Tool for In Vivo Applications.
Ludwig Maximilian University of Munich
43
Discovery of the First-in-Class Intestinal Restricted FXR and FABP1 Dual Modulator ZLY28 for the Treatment of Nonalcoholic Fatty Liver Disease.
Guangdong Pharmaceutical University
14
Design, synthesis, and properties of des-D-ring interphenylene derivatives of 1α,25-Dihydroxyvitamin D
Kanagawa University
4
Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation.
The University of Texas
2
Structure-activity relationships of 19-norvitamin D analogs having a fluoroethylidene group at the C-2 position.
Tokyo Medical and Dental University
27
Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist.
Shandong University
68
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors.
Menoufia University
4
New 2-alkylidene 1alpha,25-dihydroxy-19-norvitamin D3 analogues of high intestinal activity: synthesis and biological evaluation of 2-(3'-alkoxypropylidene) and 2-(3'-hydroxypropylidene) derivatives.
University of Wisconsin-Madison
2
Vitamin D receptor: ligand recognition and allosteric network.
Tokyo Medical and Dental University
34
Paradigm shift of "classical" HDAC inhibitors to "hybrid" HDAC inhibitors in therapeutic interventions.
National Institute of Pharmaceutical Education and Research (NIPER)
3
Design, Synthesis, Biological Activity, and Structural Analysis of Novel Des-C-Ring and Aromatic-D-Ring Analogues of 1α,25-Dihydroxyvitamin D
University of Santiago De Compostela
6
Synthesis of 1alpha,25-dihydroxyvitamin D3-26,23-lactams (DLAMs), a novel series of 1 alpha,25-dihydroxyvitamin D3 antagonist.
University of Tokyo
3
Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modificatio
Institute of Genetics and Molecular and Cellular Biology (Igbmc)
4
Novel Nonsecosteroidal Vitamin D Receptor Modulator Combined with Gemcitabine Enhances Pancreatic Cancer Therapy through Remodeling of the Tumor Microenvironment.
China Pharmaceutical University
3
Lithocholic Acid Derivatives as Potent Vitamin D Receptor Agonists.
Ochanomizu University
21
Discovery of 3α,7α,11β-Trihydroxy-6α-ethyl-5β-cholan-24-oic Acid (TC-100), a Novel Bile Acid as Potent and Highly Selective FXR Agonist for Enterohepatic Disorders.
Tes Pharma
12
Synthesis and evaluation of third generation vitamin D3 analogues as inhibitors of Hedgehog signaling.
University of Connecticut
9
Structural development of non-secosteroidal vitamin D receptor (VDR) ligands without any asymmetric carbon.
National Institute of Health Sciences
1
Development of novel lithocholic acid derivatives as vitamin D receptor agonists.
Tokyo Medical and Dental University
57
Novel nonsecosteroidal VDR ligands with phenyl-pyrrolyl pentane skeleton for cancer therapy.
China Pharmaceutical University
4
Sulfonyl-containing phenyl-pyrrolyl pentane analogues: Novel non-secosteroidal vitamin D receptor modulators with favorable physicochemical properties, pharmacokinetic properties and anti-tumor activity.
China Pharmaceutical University
18
Synthesis and evaluation of 4-cycloheptylphenols as selective Estrogen receptor-β agonists (SERBAs).
Marquette University
6
Aromatic-Based Design of Highly Active and Noncalcemic Vitamin D Receptor Agonists.
University of Santiago De Compostela
3
25 S-Adamantyl-23-yne-26,27-dinor-1α,25-dihydroxyvitamin D
Universidad De Santiago De Compostela
5
Identification of the Histidine Residue in Vitamin D Receptor That Covalently Binds to Electrophilic Ligands.
Showa Pharmaceutical University
28
Further Developments of the Phenyl-Pyrrolyl Pentane Series of Nonsteroidal Vitamin D Receptor Modulators as Anticancer Agents.
China Pharmaceutical University
3
Synthesis and biological evaluation of steroidal derivatives bearing a small ring as vitamin D receptor agonists.
Kyoto University
3
Structural Basis of Inhibition of ERα-Coactivator Interaction by High-Affinity N-Terminus Isoaspartic Acid Tethered Helical Peptides.
Shenzhen Graduate School of Peking University
9
Vitamin D Analogues with a p-Hydroxyphenyl Group at the C25 Position: Crystal Structure of Vitamin D Receptor Ligand-Binding Domain Complexed with the Ligand Explains the Mechanism Underlying Full Antagonistic Action.
Showa Pharmaceutical University
